Health
Dexamethasone drug may not benefit COVID-19 patients with diabetes or low albumin levels – News-Medical.Net
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and…
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.
Based on their findings, the researchers say doctors may need to rethink how they dose the drug for certain groups of patients.
The team of scientists, based at the University of Virginia School of Medicine, the University of…
-
Noosa News23 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station
-
Noosa News24 hours agoPappa Flock is Now Open in Westfield Chermside
-
Noosa News20 hours agoDid you lose your ring?
-
Business23 hours agoWill GQG Partners shares rise from here? Macquarie reveals its forecast post-results